Kronenberger, Bernd

Publishing since 1998 (Senior)

Has published 34 publications in 12 years

Number of publications published per year by Kronenberger, Bernd. (Source : PubMed)

Distribution of publications types for Kronenberger, Bernd. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Kronenberger B, Zeuzem S. Occludin a new HCV entry factor: is the list of essential hepatitis C virus receptors complete?  Gastroenterology  2009;137;2  
•  Kronenberger B, Zeuzem S. Current and future treatment options for HCV.  Ann Hepatol  2009;8;2  
•  Kronenberger B, Zeuzem S. Treatment of chronic hepatitis C: anticipated impact of resistance in patients treated with protease inhibitors.  Curr Gastroenterol Rep  2009;11;1  
•  Hofmann WP, Kronenberger B, Bojunga J, Stamm B, Herrmann E, Bücker A, Mihm U, von Wagner M, Zeuzem S, Sarrazin C. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.  J. Viral Hepat.  2008;15;11  
•  Raedle-Hurst TM, Welsch C, Forestier N, Kronenberger B, Hess G, Herrmann E, Zeuzem S, Raedle J. Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease.  Eur J Gastroenterol Hepatol  2008;20;9  
•  Kronenberger B, Welsch C, Forestier N, Zeuzem S. Novel hepatitis C drugs in current trials.  Clin Liver Dis  2008;12;3  
•  Kronenberger B, Zeuzem S. Future treatment options for HCV: double, triple, what is the optimal combination?  Best Pract Res Clin Gastroenterol  2008;22;6  
•  Kronenberger B, Berg T, Herrmann E, Hinrichsen H, Gerlach T, Buggisch P, Spengler U, Goeser T, Nasser S, Wursthorn K, Pape GR, Hopf U, Zeuzem S. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.  Eur J Gastroenterol Hepatol  2007;19;8  
•  Hofmann WP, Fernandez B, Herrmann E, Welsch C, Mihm U, Kronenberger B, Feldmann G, Spengler U, Zeuzem S, Sarrazin C. Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.  J. Viral Hepat.  2007;14;7  
•  Hofmann WP, Polta A, Herrmann E, Mihm U, Kronenberger B, Sonntag T, Lohmann V, Schönberger B, Zeuzem S, Sarrazin C. Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.  Gastroenterology  2007;132;3  

[ See timeline ] [ See all publications ]